Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-06

Clinical Trial Update: Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum [Phase 2, Phase 3]

View source ↗

Summary

A pediatric clinical trial evaluating local budesonide for Crohn's disease located in the esophagus, stomach, and/or duodenum, currently in Phase 2/Phase 3 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Crohn Disease (CD) | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION